ONE SENTENCE SUMMARY: MET-2/SETDB1 and interactors LIN-65/ATF7IP and ARLE-14/ARL14EP initiate heterochromatin formation during embryogenesis.
INTRODUCTION
The nucleus of a young embryo undergoes major reorganization as it transitions from a fertilized egg to a multicellular embryo. As cells acquire specific fates and zygotic transcription commences, the nucleus is segregated into distinct domains of euchromatin and heterochromatin (1). While much has been learned about the mechanisms that control cell-fate specification and the onset of zygotic transcription (2, 3) , little is understood about the processes that establish chromatin domains de novo during embryogenesis.
Heterochromatin domains are generated de novo during development (1). In early mouse embryos, embryonic stem cells and planarian neoblasts, higher-order heterochromatin is lacking, but becomes established as these cells differentiate. Their nuclei shrink, chromatin compacts, and the nucleoplasm becomes divided into visible domains of euchromatin and heterochromatin (1, 4) . In C. elegans, the dynamics of embryonic chromatin has been tracked with artificial chromosomes. These appear large and distended at the earliest stages of embryogenesis and undergo compaction during gastrulation (5, 6) . These examples suggest that the segregation of heterochromatin domains is a conserved feature of the differentiated state. Little is known, however, what drives formation of heterochromatin during embryogenesis or what determines the timing of chromatin reorganization.
Here, we characterize the regulation of MET-2 protein and its relation to heterochromatin formation during embryogenesis. We identify partner proteins that mediate MET-2 subcellular localization and chromatin association. We find that MET-2 and its partners are critical for the timely generation of heterochromatin during embryogenesis.
RESULTS
We began our analysis with a survey of wild-type embryos using two assays for heterochromatin: First, we used transmission electron microscopy (TEM). TEM studies since the 1960s have shown that heterochromatin domains can be detected as electrondense regions (EDRs), and that heterochromatin-associated histone modifications such as H3K9me are located within EDRs (7) (8) (9) (10) . Second, we surveyed histone modifications by antibody stains, to track their abundance and distribution in early embryos. Histone modifications are associated with active or silent regions of the genome, and can be a hallmark of heterochromatin (11) .
By TEM, nuclei in the youngest embryos appeared relatively homogenous, with light speckling in the nucleoplasm and a nuclear envelope free of electron-dense material ( Fig. 1A-B ). Upon initiation of gastrulation (~21-50 cell stage), embryos gained more electron-dense puncta throughout their nuclei. By mid-gastrulation (51-100 cell stage), dark material was observed abutting the nuclear envelope, and the nucleoplasmic puncta coalesced into larger, but fewer, electron-dense compartments. These features became more pronounced over time, with large EDRs that spanned the nucleus and bordered the nuclear periphery ( Fig. 1B, >200 cells) . We note that EDRs appeared throughout the embryo, suggesting that cells destined to produce different cell types nevertheless generated heterochromatin domains at about the same time in development ( fig. S1A ).
We surveyed histone modifications to determine if they were dynamic during development. There was a dramatic increase in Histone H3 Lysine 9 methylation (H3K9me) from fertilization to the mid-gastrula in interphase cells. We quantified the effect, using antibodies against histone H3 to normalize (see Methods). H3K9me2 increased ten-fold (p=4x10 -19 ), while H3K9me1 increased two-fold (p=0.001), and H3K9me3 increased six-fold (p=4x10 -7 ; Fig. 1C , D). H3K9me2 was barely detectable at fertilization, consistent with prior studies that showed H3K9me2 is erased in the germ line and undetectable in oocytes (12) . Bright H3K9me2 puncta became apparent by the 20cell stage throughout embryonic nuclei. The signal intensified during gastrulation, with more puncta and brighter staining within puncta (~51-100-cell stage, mid-stage). A time series of whole embryo stains indicated that most interphase nuclei behaved similarly (fig. S1B), and two different antibodies against H3K9me2 gave identical results (fig. S1C).
Controls indicated that the signal was specific because mutants lacking H3K9me2 (12, 13) failed to stain with any of the H3K9me2 antibodies (fig. S1D-E). Both puncta of histone modifications and EDRs arose during gastrulation, suggesting H3K9me stains are a useful proxy to visualize heterochromatin domains.
Not all histone modifications were developmentally regulated (Fig. 1C, fig. S1B ).
The Polycomb-mediated modification H3K27me3 was abundant in early embryos and did not increase further, as observed previously (14) . This result indicates that H3K27me3 is not sufficient for higher-order heterochromatin. Pan H4 acetylation, a modification associated with active chromatin, was present in early embryos before the onset of zygotic transcription and increased slightly over time. This observation reveals that bulk loss of H4Ac is not required for higher-order heterochromatin. In short, only some modifications were regulated dynamically during embryogenesis.
To identify the molecular basis of heterochromatin formation, we focused on the methyltransferase MET-2. MET-2 is homologous to vertebrate SETDB1 (15, 16) , and required for virtually all H3K9me1 and H3K9me2, and for some H3K9me3 (12, 13) . We focused on H3K9me2 and MET-2 because H3K9me2 was regulated most dynamically during embryogenesis, because it promotes H3K9me3 (12) , and because its location in the genome, by ChIP, tracks well with canonical heterochromatin proteins such as HPL-2/HP1 (17) .
We asked whether loss of MET-2 impacted heterochromatin domains visible by TEM. Pre-gastrula met-2 embryos matched their wild-type counterparts, with homogeneous, translucent nuclei ( Fig. 2A ). However, the speckles observed in wild-type nuclei at the 20-cell stage were dimmer in met-2 mutants, and they failed to coalesce into EDRs by the 50-100-cell stage ( Fig. 2A ). EDRs emerged in older embryos, but they occupied less nuclear volume and were reproducibly paler than the wild type ( Fig. 2A ).
We performed line-scan analysis to quantify the appearance of nuclear EDRs. The standard deviation of line-scan values is higher in nuclei with EDRs compared to homogeneous nuclei because the dark EDRs contrast with the pale nucleoplasm. met-2 nuclei had a more homogeneous distribution of signal and a smaller standard deviation at every stage ( Fig. 2B ). To assess the amount of residual electron density in met-2 late embryonic nuclei (>200 cell stage), we used an intensity threshold to define EDRs in wildtype and met-2 embryos (Fig. 2C ). The percentage of pixels in EDRs was reduced almost three-fold in met-2 mutants compared to the wild type ( Fig. 2C ). To control for TEM fixation and sectioning, we examined cytoplasmic organelles and yolk droplets. Intensity thresholding revealed that electron-dense cytoplasmic structures were present in met-2 mutants ( Fig. 2D ) and they resembled those in wild-type embryos ( fig. S2A These data may help resolve a controversy regarding where MET-2 is localized within cells (13, (18) (19) (20) . A previous study had concluded that MET-2 was cytosolic (13), whereas other work had suggested that MET-2 associated with chromatin (19) in the nucleus (20) . Our data reveal that MET-2 transitions from the cytosol to the nucleus (Fig.   3A ), a process that is regulated by its binding partner LIN-65 (see below and Discussion).
Given that met-2 is necessary for heterochromatin domains, and that H3K9me2 accumulated dynamically in early embryos, we asked whether regulation of MET-2 constituted part of the embryonic timer for heterochromatin establishment. We hypothesized that if nuclear MET-2 was rate-limiting, then premature accumulation of MET-2 in nuclei would lead to precocious H3K9me2 and initiate heterochromatin. We added a nuclear localization signal (NLS) from c-Myc to a FLAG-tagged copy of endogenous MET-2 using Crispr and examined embryos for H3K9me2 and histone H3 (a control for staining). We note that H3 appears to be released during mitosis, but our quantitation focused only on interphase cells.
Addition of an NLS resulted in a two-fold increase in nuclear MET-2 in pre-gastrula embryos ( To understand how MET-2 is regulated, we searched for binding partners using immunoprecipitation followed by Multidimensional Protein Identification Technology Mass Spectrometry, using MET-2::GFP and 3xFLAG::MET-2. Wild-type C. elegans bearing no tagged proteins, and strains bearing an unrelated GFP or FLAG reporter served as negative controls. Results of our MET-2::GFP proteomics analysis can be found in Supplementary Table 1 . We chose a candidate list of interacting partners based on the specificity of MET-2 binding, on the peptide counts and on protein coverage. We To test the role of the MET-2 binding partners in H3K9me deposition, we analyzed loss-of-function mutants. lin-65 mutants had dramatically reduced levels of H3K9me1 and H3K9me2, and low H3K9me3 (Fig. 4A, B ). Wild-type embryos had puncta of H3K9me3 and a large standard deviation of line-scan values, whereas met-2 and lin-65 mutants each had dispersed H3K9me3 with a more uniform distribution in the nucleus ( Fig. 4C -D). Thus, lin-65 mutants resembled met-2 mutants, suggesting it is an essential cofactor.
On the other hand, arle-14 mutants had reduced H3K9me1/me2 levels and largely normal H3K9me3 ( Fig. 4A, B) . These mutants were similar to a partial loss of met-2 activity, suggesting arle-14 is less critical than lin-65.
lin-65 and arle-14 resembled met-2 mutants in two additional assays. First, an important role of MET-2 is to silence repetitive DNA (19, 21) . RNAs for two repeats were de-repressed by arle-14 mutations and, to a greater degree, by lin-65 ( Fig. 4E ). Second, de-repressed repeats lead to a mortal germline phenotype for met-2 mutants at 26°C (21) .
Similarly, lin-65 mutants became sterile after a single generation, and arle-14 mutants after two generations (n=80 worms, Generation 1: 20% sterility, Generation 2: 100% sterility). These results indicate that LIN-65 and ARLE-14 are bona fide binding partners for MET-2 and contribute to its functions.
To address whether LIN-65 and ARLE-14 contribute to the onset of heterochromatin formation, we examined their expression during embryogenesis. We generated an antibody against bacterially-produced ARLE-14 and inserted a 3xFLAG tag at the carboxyl terminus of endogenous LIN-65 by Crispr. Both proteins behaved similarly to MET-2: they were enriched in the cytoplasm from the one-cell stage through the eightcell stage, but gradually moved into nuclei thereafter; total levels did not change ( fig. S4C , D). During gastrulation, we observed concentrated hubs of MET-2, LIN-65 and ARLE-14 emerge within nuclei ( Fig. 4F , H, I, J). The hubs were visible by eye within nuclei and defined more rigorously with an intensity threshold ( Figure 4F ). H3K9me2, MET-2, LIN-65 and ARLE-14 co-localized in hubs, and these excluded the activating mark H3K4me3 ( Fig. 4G ). MET-2 and its binding partners never excluded each other in the nucleus, but we frequently observed intense hubs of one protein that did not overlap with each other ( Fig. 4G ). This result suggests that although these proteins bind each other, they are not always co-localized in the cell, and that binding interactions may be specific to certain regions or functions. To begin to address how ARLE-14 contributes to the deposition of H3K9me2 by MET-2, we examined MET-2 in wild-type and arle-14 embryos. Neither the localization nor the level of MET-2 changed in arle-14 mutants ( Fig. 5A-B ). On the other hand, expression of ARLE-14 tracked extremely well with MET-2 ( Fig. 5C-D) . In wild-type embryos, ARLE-14 was predominantly nuclear but in met-2 mutants lacking MET-2 protein, ARLE-14 was lost, suggesting that MET-2 is required for ARLE-14 stability or accumulation. These data indicate that arle-14 is not required to localize MET-2 into nuclei.
Next, we used ChIP-seq to determine whether arle-14 affects the genome-wide location of H3K9me2 or MET-2. The distribution of H3K9me2 was normal in arle-14 mutants (wild-type vs. arle-14 gave a genome-wide correlation of 0.86 and 0.66 for two independent experiments) ( Fig. 5E-F ). We conclude that ARLE-14 is not required to target MET-2 in the genome. We also examined the level of H3K9me2 quantitatively. ChIP-Seq experiments are rarely quantitative, due to the methods of sample isolation and library preparation (see Methods). Thus, while ChIP-Seq can reveal where H3K9me2 is located in the genome, it does not reveal how much. To quantify the level of H3K9me2, we used ChIP-qPCR on material prior to DNA amplification and normalized to input DNA.
H3K9me2 ChIP-qPCR confirmed the decrease in H3K9me2 levels in arle-14 mutants ( Fig. 5G ), similar to immunostaining results (Fig. 4A ). These findings indicate that H3K9me2 is in the right places in the genome, but at a reduced level. Prior to this study, ARLE-14 was an uncharacterized C. elegans protein with homology to ADP Ribosylation Factor Like 14 Effector Protein (ARL14EP; Fig. 5K ). In vertebrates, the only published function for ARL14EP is in the cytoplasm (22) . However, the Protein Atlas shows ARL14EP in the nuclei of many human tissues (www.proteinatlas.org). We surveyed large-scale interaction databases (23) (24) (25) and uncovered an interaction between ARL14EP and SETDB proteins in both humans and Drosophila (Fig. 5L ). We suggest that, in addition to its cytoplasmic function, ARLE-14 and its orthologues function in nuclei with SETDB methyltransferases.
Next, we examined LIN-65. In lin-65 mutants, MET-2 remained cytoplasmic ( Fig.   6A, fig. S5A ), as did ARLE-14 ( Fig. 5C ). MET-2 levels did not decrease in lin-65 mutants These results indicate that LIN-65 is rate-limiting for nuclear accumulation of MET-2 and H3K9me.
lin-65 belongs to the synMuv B subclass of regulators, which are involved in chromatin regulation and transcriptional repression (26) . Although lin-65 had been annotated as a novel protein (18, 27) , we found similarities between LIN-65 and the cofactor Activating Transcription Factor 7-Interacting Protein (ATF7IP; Fig 6G) . Like ATF7IP, LIN-65 has a high-probability coiled-coil region predicted by PCOILS (CC) and a high-confidence beta-sandwich in the C-terminus (S) embedded within extensive disordered sequences ( fig. S5G-H) . Like LIN-65, ATF7IP binds and localizes SETDB1 to nuclei (28) (29) (30) . Despite these similarities, LIN-65 is not an obvious orthologue of ATF7IP and may be an example of convergent evolution.
DISCUSSION
De novo generation of heterochromatin domains is a conserved feature of embryogenesis, but it was previously unclear how timing was established. This study revealed that heterochromatin onset depends on the gradual accumulation of MET-2 within nuclei. Relocation depends on two MET-2 binding partners: LIN-65 is critical for MET-2 nuclear localization, and ARLE-14 is important for MET-2 to associate with chromatin. Naturally, these activities do not rule out additional roles for MET-2 regulation by LIN-65 and ARLE-14.
Similar to C. elegans, mammals and Drosophila rebuild heterochromatin domains during embryogenesis (1, 31). More generally, lack of heterochromatin domains appears to be a feature of undifferentiated cells, including embryonic stem cells and planarian neuroblasts, and differentiation involves re-establishing heterochromatin (1). Examination of previous studies suggest murine SetDB1 is cytoplasmically enriched in early embryos, but its function has been difficult to address due to early lethality (32, 33) . An intriguing idea is that nuclear localization of SETDB with ATF7IP and ARL14EP initiates heterochromatin formation in other animals as well.
The localization of MET-2 in C. elegans cells had previously been controversial.
One study argued MET-2 was cytoplasmic (13) while another demonstrated that MET-2 was required for nuclear localization of LIN-65 under mitochondrial stress conditions, but MET-2 itself was assumed to be cytosolic (18) . On the other hand, ChIP experiments had suggested that MET-2 associated with chromatin, implying a nuclear focus (19) (20) . One possibility is that excess MET-2 may overwhelm LIN-65 and accumulate in the cytosol under conditions where native MET-2 would be nuclear.
What is the function of de novo H3K9me and heterochromatin formation during embryogenesis? It has been proposed that generation of heterochromatin is critical for loss of pluripotency and restriction of cell fate during gastrulation (34) . In support of this notion, H3K9 methylation can act as an epigenetic barrier against reprogramming cells into a pluripotent state (35) . In addition, absence of heterochromatin in early embryos may provide a brief window where repetitive sequences are transcribed, which is a prerequisite for initiating silencing (36) .
Alterations in H3K9 methylation has been observed in polycystic ovary syndrome (PCOS), a frequent cause of infertility in women (37, 38) . PCOS leads to a range of defects including aberrant oocyte morphology and an increased incidence of miscarriage (39) . ARL14EP was identified by GWAS as a promising candidate for PCOS (40) . It is intriguing to speculate that there may be a link between ARL14EP and H3K9 methylation in PCOS.
MATERIALS AND METHODS

Number of experiments and embryos surveyed.
For imaging experiments, first, many embryos were surveyed under the microscope through the eye piece and general trends noted. Then a random subset of embryos was imaged and analyzed more deeply, with quantitation. Details of analysis are described separately in the Image analysis section, and the analysis gave the same qualitative result as the trends observed in the initial survey. 4A . We analyzed the following number of embryos in N=3 experiments: H3K9me1:
WT vs. met-2(ok2307) (5, 7), WT vs. lin-65(n3441) (8, 12) , WT vs. arle-14(tm6845) (6, 7) . H3K9me2: WT vs. met-2(ok2307) (11, 20) , WT vs. lin-65(n3441) (10, 13) , WT vs.
arle-14(tm6845) (22, 21) . H3K9me3: WT vs. met-2(ok2307) (14, 12) , WT vs. lin-65(n3441) (6, 6) , WT vs. arle-14(tm6845) (5, 6) . 
Strains
Worms were maintained at 20 o C, unless stated otherwise. A full list of strains used in this study, their maintenance conditions and construction of strains generated in this study can be found in the supplement.
Antibody staining
Details of the staining protocol and a full list of antibodies used in this study are available in the supplement, together with a description of how antibodies against endogenous MET-2 or ARLE-14 were generated. For mutant configurations, an on-slide wild-type sample was included, marked with a single-copy ZEN-4::GFP tag. On-slide controls allowed better quantitation between different genotypes or stages.
TEM
Adult hermaphrodites were rapidly chilled in liquid nitrogen while exposed simultaneously to very high pressure (2100 bar). This combination preserves the morphology of organelles and finer structures. Frozen samples underwent freeze substitution to deposit osmium tetroxide for contrast and fixation. Worms were embedded and sectioned along the ovary to view multiple embryos in a row. A detailed protocol is available in the supplement.
Proximity Ligation Assay
Sigma Duolink In Situ Kit (DUO92101) was used for this assay. Embryos were fixed as for regular antibody staining. After overnight staining with primary antibodies at 15 o C, the sample was stained at 37 o C for 1 hour with secondary antibodies that have oligonucleotide probes attached. Connector oligos were hybridized to the probes and served as templates for circularization by enzymatic ligation when in close proximity. The ligation reaction was incubated at 37 o C for 30 minutes. The circularized DNA strands were used for rolling circle amplification (RCA) and the RCA product was detected by hybridizing fluorescently labeled oligos. The RCA reaction was incubated at 37 o C for 100 minutes. After each step, slides were washed with TBS + 0.2% TritonX for 5 minutes.
Slides were mounted in DAPI.
Microscopy and image analysis
Histone modifications. Stacks of optical sections were collected with a ZEISS LSM700 or LSM880 Confocal Microscope and analyzed using Volocity Software. Details of the quantitation by Volocity can be found in the supplement. Signal intensity for histone modifications was normalized to signal intensity for unmodified histones for each nucleus.
Normalized values were averaged at given embryonic stages and plotted. (Fig. 1D, 2D , 2E, 2J, 3B, 4E, S1D, S3C, S3D). TEM Image processing. Raw images were processed with Photoshop as 8-bit gray scale images. Images from different preparations were standardized for accurate comparison.
The cytoplasm was used to adjust signal intensity range for each image, but image contrast was not altered. Adjusted images were then saved and quantified with Image J by Line scan analysis.
TEM/H3K9me3 Line scan analysis:
Random lines were drawn across the center of different nuclei, and the intensity measured. Standard deviation was calculated for each individual line. Standard deviation of 30 lines were averaged for each strain and listed on the plot. A randomly selected line profile for a nucleus is shown as an example (Fig. 2B for TEM and Fig. 4D for H3K9me3). The standard deviation describes the morphology of the nucleus, i.e. a higher standard deviation stems from a more punctate staining pattern that alternates between high and low values (ie electron dense heterochromatin and electron lucent nucleoplasm or H3K9me3 positive and negative regions in the nucleus).
TEM percentage of EDR. A black and white image was created for each nucleus in
ImageJ using the thresholding function. The threshold was chosen manually to best reflect EDRs in >200-cell wild-type embryos and was used to quantify all nuclei (threshold: . The inner nuclear membrane was manually traced to define an outer most ring, and the number of black vs. total pixels within the ring were used to quantify %EDRs.
MET-2/ARLE-14/LIN-65 Line scan analysis:
Lines that go through the center of the nucleus were drawn across the cell, and the intensity measured. Each line had 100 bins.
The intensity in each bin was averaged for 30 lines, and the average line plotted. Error bars denote the standard error of the mean at each bin ( Fig. 3G, 5B , 5D, 6B, S5C, S5F).
Definition and Quantitation of hubs. Nuclear hubs were defined by intensity thresholding in ImageJ. The threshold was selected manually in wild-type nuclei at the 51-100 cell stage and the same threshold was applied to all the images in a given dataset.
The intensity measurements for each defined hub were averaged to yield the intensity of "hubs" at given embryonic stages. "Non-hub" was defined as nuclear areas that were below the intensity threshold. The mean intensity in non-hub areas was measured for each nucleus and averaged across 30 nuclei. Non-interphase nuclei were discarded manually. For intensity measurements in the cytosol, at least 4 random areas in the cytosol was chosen for every cell that was in interphase. The measured intensities were averaged.
Half-dose LIN-65 experiments
lin-65 (n3441) moms were crossed with JAC500 his-72::mCherry males. Progeny of lin-65+/-heterozygotes marked by mCherry were analyzed. On the same slide, SM2333 containing a single copy of zen-4::gfp was used as a wild-type staining control. Mean H3K9me2 or H3K9me3 intensity in each nucleus was quantified using Volocity and the average H3K9me2 or H3K9me3 intensity per nucleus plotted, normalized as described in the staining section.
Biochemistry and Bioinformatics
Detailed protocols for harvesting embryos, Immunoprecipitation (IP), mass spectrometry (MS), RNA expression, ChIP-Seq and analysis of sequencing data can be found in the supplementary materials and methods. Inset shows H3K4me3 ChIP-qPCR as a control. The y-axis shows normalized %input values for both wild-type and mutants, where the %input value at the H3K4me3 positive region was set to 1 for both genotypes. %input for MET-2::GFP ChIP was adjusted accordingly. Error bars denote standard error of the mean for N=3 experiments. I-J. Acquisition of H3K9me2 in wild-type vs. arle-14 mutants during embryogenesis, with an H3 co-stain (D) and quantitation normalized to H3 (E). Error bars denote standard error of the mean. K. Amino acid sequence alignment of worm ARLE-14 to the human ARL14EP domain using ClustalX2. Color scheme: Hydrophobic-blue, Positive charge-red, Negative charge-magenta, Polar-green, Cysteines-pink, Glycines-orange, Prolines-Yellow, Aromatic-cyan. L. Protein interaction map for human ARL14EP from String database (https://stringdb.org/). Red box highlights interactions with human SETDB1/2. Fig. 6. LIN-65 is rate-limiting for H3K9me2 and nuclear MET-2 during embryogenesis. A. Distribution of MET-2::GFP in wild-type vs. lin-65 mutants vs. no-GFP wild-type strain (Scale bar, 2 μm). Note that this H3 antibody detects mostly cytosolic histone H3 during mitosis. B. Line-scan analysis across embryonic nuclei shows mean MET-2::GFP intensity in wild-type (green) vs. lin-65 (pink) mutants vs. no-GFP control ("-", grey). Average of line scans across multiple nuclei are shown and error bars denote standard error of the mean. C,E. H3K9me2 and H3K9me3 levels in embryos with a single copy ZEN-4::GFP ("WT", on-slide control) or progeny of lin-65(+/-) heterozygous mothers identified by HIS-72::mCherry at designated stages of embryogenesis. D,F. Quantitation of H3K9me2 and H3K9me3 levels from wild-type (grey) or lin-65(-/+) (purple) offspring. Error bars denote standard error of the mean. G. Domain architecture from HMMR (https://www.ebi.ac.uk/Tools/hmmer/) for human ATF7IP, fly Windei and worm LIN-65 showing disordered (purple), coiled-coil (pink), and beta-sandwich fold (violet) regions. H. In early embryos, MET-2 (grey), LIN-65 (red) and ARLE-14 (yellow) are enriched in the cytosol, and there is little H3K9me2 or heterochromatin (light green). As embryos mature, MET-2 and interactors gradually accumulate in nuclei, form concentrated nuclear hubs and deposit H3K9me2. MET-2-dependent H3K9 methylation is required to generate heterochromatin domains (compacted, dark green).
